Mifepristone treatment of chronic central serous chorioretinopathy

Jared S. Nielsen, Robert N. Weinreb, Lawrence Yannuzzi, Lee Merrill Jampol*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


Antiglucocorticoid therapy has been hypothesized to be beneficial in the treatment of central serous chorioretinopathy (CSC). We report a case of severe chronic CSC with a favorable response to oral mifepristone, a potent antiglucocorticoid medication.

Original languageEnglish (US)
Pages (from-to)119-122
Number of pages4
Issue number1
StatePublished - Jan 1 2007

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems


Dive into the research topics of 'Mifepristone treatment of chronic central serous chorioretinopathy'. Together they form a unique fingerprint.

Cite this